Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world... Show more
USANA Health Sciences is in the middle of a strategic transformation from a direct-selling nutrition company into an omnichannel health and wellness business spanning three segments: Core Nutritional, the children's vitamin brand Hiya, and Rise Wellness. This third-quarter report matters because it tests whether that turnaround is gaining traction. Recent quarters have been marked by shrinking active customers, softer sales, and profitability pressure from investments in a revamped Brand Partner compensation plan. With the company holding $179 million in cash and zero debt, investors are watching closely to see whether management's spending on customer acquisition and product innovation can translate into renewed revenue growth without further eroding margins.
For its fiscal third quarter ended October 3, 2026, USANA reported net sales of $206 million, down 4% from $214 million a year earlier and below the roughly $217 million analysts had expected. Net loss attributable to USANA was $5.6 million, an improvement from a $6.5 million loss in the prior-year period. Diluted EPS was a loss of $0.30, compared with a loss of $0.36 a year ago.
On a non-GAAP (non-Generally Accepted Accounting Principles) basis, adjusted diluted EPS was a loss of $0.11, versus a loss of $0.15 in the prior-year quarter, but still far short of consensus estimates that had anticipated a small profit. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) attributable to USANA was $12.1 million, down from $13.8 million a year earlier and below the approximately $12.8 million analysts expected.
Management also revised its fiscal 2026 outlook lower. The company now expects consolidated net sales approaching $900 million and adjusted EBITDA of $77 million, reductions from its prior forecasts of $910 million in net sales and $80.5 million in adjusted EBITDA.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and exchange-traded funds (ETFs) with customizable filters for industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is built to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, making it a practical resource for investors looking to refine their watchlists with data-backed signals.
The market's response was sharply negative. Shares dropped roughly 14.9% to around $12.65 immediately after the announcement, according to market data, as investors focused on the revenue miss and the reduced full-year outlook rather than the sequential subscriber gains at Hiya. The lower guidance, particularly the cut to adjusted EBITDA, signaled to the market that near-term profitability challenges are expected to persist.
Sentiment heading into the report was already cautious following several quarters of declining active customers and margin pressure. The post-earnings selloff suggests that investors viewed the results as confirmation that the company's transformation is taking longer and costing more than anticipated, even as management pointed to improving operating margins in the Core Nutritional segment and strengthening traction at Hiya.
Looking ahead, investors will be watching whether Hiya's momentum can be sustained. The brand added roughly 29,500 net active monthly subscribers during the quarter and returned to year-over-year sales growth, helped by increased marketing spend and expanding distribution through retailers such as Target and Amazon. Because Hiya operates largely as a subscription business, subscribers added now are expected to support revenue in future quarters.
Rebuilding the Core Nutritional active customer base remains the company's stated top priority and its largest growth lever. Management is evolving its Brand Partner incentive plan to more directly reward customer growth and plans to introduce new products beginning in 2027. Early signs, such as a 3% sequential increase in Southeast Asia Pacific active customers, suggest the strategy can work where execution aligns, but the broader customer base is still shrinking.
Finally, the company's balance sheet provides flexibility. With $179 million in cash, no debt, and $36 million in year-to-date free cash flow, USANA can continue investing in its omnichannel strategy. However, the reduced guidance indicates these investments will continue to weigh on near-term profitability, making the pace of subscriber and customer recovery the key metric to track in the quarters ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Develops and manufactures nutritional, personal care and weight-management products
Industry FoodMajorDiversified